Research
Evidence-based research
Clear guides to GLP-1 medicines, costs, coverage and safety, grounded in 112 primary sources. Explore 51 guides or compare all 548 provider reviews.
51
Guides
112
Sources
33
Studies
Drug guides
Start with the medicine: approved forms, what the evidence says, pricing and safety questions to discuss with your clinician.
Semaglutide: Treatment Choices, Costs, and Safety Guides
A starting point for semaglutide research: Wegovy treatment forms, compounded-drug distinctions, costs, eligibility, and provider comparisons.
3 cited sources · updated
Tirzepatide: Zepbound, Costs, Coverage, and Provider Guides
Explore Zepbound evidence, device choices, insurance, compounded tirzepatide costs, and the safety questions to bring to a clinician.
2 cited sources · updated
Orforglipron and Foundayo: Pill, Price, and Coverage Guide
Understand Foundayo’s active ingredient orforglipron, daily dosing routine, current prices, coverage routes, and comparison with Wegovy pill.
2 cited sources · updated
Zepbound vs Wegovy: Weight Loss, Cost, and Which Fits
Compare Zepbound and Wegovy using head-to-head research, current treatment choices, and the costs that matter after the first prescription.
5 cited sources · updated
Foundayo vs Zepbound vs Wegovy Pill: A Practical Comparison
Compare daily instructions, clinical evidence, and ongoing costs for Foundayo, Zepbound, and Wegovy pill without mixing up their trials.
6 cited sources · updated
Retatrutide in 2026: Results, Risks, and Approval Status
What retatrutide’s trials show, what is still investigational, and why an online “research peptide” is not an approved prescription alternative.
6 cited sources · updated
Prices, savings and coverage
Compare the actual payment route: cash, manufacturer savings, commercial insurance or Medicare. Eligibility and refill terms matter as much as the first price.
Foundayo Price: Dose-by-Dose Costs and Coverage
Foundayo self-pay prices by dose, the temporary 2026 discounts, insurance savings, and how to budget beyond the starting tablet.
3 cited sources · updated
Compounded Tirzepatide Cost: A 36-Provider Price Snapshot
A dated snapshot of 36 plain monthly tirzepatide listings, with the median, price distribution, and the limits behind the numbers.
2 cited sources · updated
Zepbound Coupon and Savings Card: Who Qualifies?
Understand Zepbound’s commercial savings card, the $25 and $499 headlines, separate self-pay options, and what to check at the pharmacy.
3 cited sources · updated
Does Insurance Cover Zepbound? Aetna, Cigna, BCBS, and UHC
A plan-specific guide to Zepbound coverage, public insurer policy examples, prior authorization, denials, and the sleep-apnea indication.
4 cited sources · updated
Does Medicare Cover Wegovy or Zepbound? The $50 Bridge
Who can use Medicare’s $50 GLP-1 Bridge, which products qualify, how approval works, and why the copay differs from normal Part D expenses.
3 cited sources · updated
Treatment questions
Practical, cited explanations of side effects, treatment timelines, injection devices and post-shortage compounding rules.
Tirzepatide Constipation: What to Check and When to Get Help
Constipation is common with Zepbound, but severe pain, vomiting, or inability to pass gas need assessment. Understand rates and care options.
3 cited sources · updated
Semaglutide Sulfur Burps: What the Evidence Actually Shows
Burping is reported with semaglutide, but odor alone cannot diagnose gastroparesis or infection. Understand evidence gaps, useful checks, and red flags.
3 cited sources · updated
GLP-1s Before Surgery: Current Guidance and What to Ask
Current guidance favors individualized GLP-1 decisions before anesthesia. Understand older hold advice, the 2026 endoscopy trial, and questions for your team.
6 cited sources · updated
What Happens When You Stop a GLP-1? Weight Regain and Planning
What semaglutide and tirzepatide withdrawal trials found, why regain is not inevitable for everyone, and how to plan a treatment interruption.
4 cited sources · updated
GLP-1 Microdosing: What the Evidence Can and Cannot Tell You
Understand what “microdosing” means, why lower-dose care is not a proven longevity protocol, and what to ask about safety, price, and evidence.
4 cited sources · updated
Oral Tirzepatide and Gummies: What Is Actually Approved?
An oral or gummy tirzepatide offer is not FDA-approved Zepbound. How formulation, absorption, evidence, pharmacy checks, and pricing differ.
5 cited sources · updated
GLP-1s and Alcohol: What the Semaglutide Trials Found
Semaglutide alcohol trials show promise, but GLP-1s are not approved alcohol-use treatments. Understand the evidence, limitations, and drinking questions.
6 cited sources · updated
GLP-1s and Gastroparesis: What “Stomach Paralysis” Means
Delayed stomach emptying is not automatically gastroparesis. Understand the evidence, absolute rates, warning symptoms, and questions for your clinician.
4 cited sources · updated
GLP-1s, Depression, and Suicidal Thoughts: The 2026 FDA Update
FDA requested removal of the GLP-1 suicidality warning in January 2026. What the evidence says, its limits, and why new mood symptoms still deserve care.
3 cited sources · updated
How to Check a GLP-1 Pharmacy Before You Pay
Verify the actual dispensing pharmacy, state license, 503B listing, inspections, and recalls. Understand what each check proves and what it does not.
5 cited sources · updated
Zepbound Side Effects: Trial Rates and When to Get Help
Zepbound nausea, vomiting, diarrhea, and constipation rates by dose, how to read the numbers, and symptoms that need medical attention.
3 cited sources · updated
How Long Does Zepbound Take to Work? A Realistic Timeline
Separate early appetite changes from long-term Zepbound weight loss, understand titration, and know why alcohol research does not establish a safe limit.
4 cited sources · updated
Zepbound KwikPen vs Vials: Prices and Practical Differences
Compare Zepbound KwikPen and single-dose vials, current self-pay dose prices, refill conditions, and the Medicare device rule.
5 cited sources · updated
Is Compounded Semaglutide Still Legal? October 2026 Update
The current FDA rules for compounded semaglutide, why vitamin add-ins do not settle legality, and the questions to ask before your next refill.
4 cited sources · updated
The medicine
What the molecules do, what the pivotal trials actually showed, and what separates an FDA-approved product from a compounded one. Every efficacy and regulatory claim in this group is cited to a primary source.
Semaglutide vs Tirzepatide: What the Head-to-Head Trial Shows
SURMOUNT-5 directly compared tirzepatide with injectable semaglutide for obesity. Understand the results, doses, limitations, safety, and care costs.
4 cited sources · updated
Compounded vs Brand-Name GLP-1: Which Should You Choose?
Brand-name GLP-1 is FDA-approved and consistent; compounded is cheaper and more available but not FDA-approved. Here is how to decide honestly.
5 cited sources · updated
Is Compounded Semaglutide Legit and Safe? What to Verify Now
Compounded semaglutide is not FDA approved. Check current legal limits, the dispensing pharmacy, ingredients, evidence, and measuring instructions.
4 cited sources · updated
The market, and what it costs
What a month of compounded GLP-1 really costs across the providers we track, and how the regulatory ground under compounded supply has shifted underneath those prices.
What Compounded GLP-1 Costs Per Month
Compare current compounded GLP-1 prices, upfront payments, refill intervals and separate care fees. A monthly equivalent is not always a monthly bill.
5 cited sources · updated
What the End of GLP-1 Compounding Means for You
The FDA shortage that made compounded semaglutide and tirzepatide widely available is over. Here is who can still get compounded GLP-1 and who must switch.
7 cited sources · updated
How we judge a provider
The rubric itself, and the checklist a reader can run without us. These two explain what the Verdict Score measures and why those six things rather than another six.
How We Grade GLP-1 Providers: The Verdict Score Explained
The Verdict Score rates every GLP-1 provider out of 100 on six weighted factors — the same rubric for every provider, and the score is never sold.
3 cited sources · updated
How to Choose a GLP-1 Telehealth Provider
An 8-point checklist for comparing GLP-1 telehealth providers: medication, total cost, prescribers, pharmacy verification, support, and cancellation.
6 cited sources · updated
Also in the library
Does Semaglutide or Tirzepatide Cause Hair Loss?
What observational studies show about hair loss during GLP-1 treatment, why the cause remains uncertain, and when to ask a clinician for help.
5 cited sources · updated
Do GLP-1 Weight-Loss Patches Actually Work?
How consumer GLP-1 patches differ from approved medicines, why passive skin delivery is difficult, and what microneedle research does not prove.
6 cited sources · updated
GLP-1s, Pregnancy, and Breastfeeding: What the Label Actually Says
Compare Wegovy and Zepbound pregnancy instructions, tablet-specific breastfeeding guidance, and the limits of milk-transfer studies.
4 cited sources · updated
“Ozempic Face”: What Causes Facial Fat Loss on a GLP-1 (and What Helps)
What “Ozempic face” means, how facial volume can change with weight loss, and what the dermatologic-surgery literature says about treatment.
3 cited sources · updated
Semaglutide or Tirzepatide Diarrhea: Dehydration and Care
Diarrhea can occur with semaglutide or tirzepatide. Learn what to record, when to seek help, and why hydration and medication review matter.
4 cited sources · updated
Can GLP-1 Medicines Cause Kidney Problems? Risk and Benefits
Understand dehydration-related kidney injury warnings for semaglutide and tirzepatide, and why specific kidney-benefit trials do not cancel those risks.
7 cited sources · updated
Semaglutide Heartburn: Reflux Rates, Relief, and Warning Signs
Can semaglutide cause heartburn? See Wegovy reflux rates, practical meal changes, medicine questions, and symptoms that need medical attention.
5 cited sources · updated
Semaglutide Injection-Site Reactions: Rash, Itching, and Red Flags
Understand semaglutide injection-site itching, redness, and lumps, the limits of trial rates, and when infection or a serious allergy needs urgent care.
4 cited sources · updated
Semaglutide Nausea and Vomiting: What Helps, What Needs Care
Why semaglutide can cause nausea, what trial rates mean, reasonable food changes, and when vomiting or dehydration needs medical assessment.
4 cited sources · updated
Tirzepatide Fatigue: Trial Rates, Possible Causes, and Next Steps
Tired on tirzepatide? Compare Zepbound fatigue rates with placebo, understand other possible causes, and recognize symptoms that need prompt care.
3 cited sources · updated
GLP-1 Drug Interactions: Semaglutide, Tirzepatide, and Oral Options
Check the exact product: tirzepatide contraception precautions, oral semaglutide timing, and Foundayo CYP3A4 interactions require different plans.
3 cited sources · updated
Who Qualifies for a GLP-1—and Who Should Not Take One
GLP-1 eligibility depends on the drug, indication, age, and history. Understand BMI thresholds, contraindications, oral options, and procedure planning.
5 cited sources · updated
Semaglutide and NAION Vision Loss: The EMA Safety Finding
EMA classifies NAION as a very rare semaglutide side effect. Understand absolute versus relative risk and why sudden vision changes need urgent care.
2 cited sources · updated
GLP-1 Weight-Loss Plateau: What to Review Before Changing Treatment
A slower scale trend is not an automatic reason to raise the dose or switch. Review measurement, treatment access, symptoms, and evidence with your clinician.
4 cited sources · updated
Compounded Semaglutide Dosing Errors: What the FDA Safety Alert Says
The FDA has received reports of hospitalizations from dosing errors with compounded semaglutide vials. Here is exactly what goes wrong, and how to avoid it.
2 cited sources · updated
GLP-1s and Sleep Apnea: What Zepbound's OSA Approval Actually Means
Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity. Here is the SURMOUNT-OSA trial data and what it means for you.
5 cited sources · updated
GLP-1s, Your Gallbladder, and Your Pancreas: What the Trials Actually Show
Rapid weight loss and GLP-1s both raise gallstone risk, and pancreatitis is a labeled warning on both drugs. Here are the actual trial rates and warning signs.
3 cited sources · updated
How Much Muscle Do You Lose on Semaglutide or Tirzepatide?
Body-composition substudies show roughly a quarter to a third of GLP-1 weight loss is lean mass, not fat. Here is the actual data and how to protect it.
3 cited sources · updated
The GLP-1 Thyroid Cancer Boxed Warning, Explained
Wegovy and Zepbound carry a boxed warning for thyroid C-cell tumors, based on rodent studies. Here is what it says, who it excludes, and what human data show.
4 cited sources · updated
Where the research meets the reviews
The evidence above decides what a good program looks like; the 548 provider verdicts decide which ones clear the bar. Pricing is the half that has to be re-read rather than cited: figures come from each provider's own live pages, they carry the condition attached to them, and when we read one back against the provider's site and find it wrong we correct it in public. Who writes this, and how corrections are handled, is in our editorial policy.